Knowledge Distillery

Although COVID-19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke,…

Parkinson’s disease (PD), possibly due to associated factors. This study aimed to systematically review the factors associated with COVID-19 in people…

Central and peripheral nervous system involvement during acute COVID-19 is well known. Although many patients report some subjective symptoms months…

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, neurological symptoms increasingly moved into the focus of interest.

Reports indicate an increased risk of ischemic stroke during coronavirus disease 2019 (COVID-19) infection.

This study assessed the prevalence and risk factors for SARS-CoV-2 infection in patients with epilepsy (PWE). Additionally, the course of COVID-19 and…

Parkinson’s Disease (PD) is among one of the common comorbidities in older patients. People with PD may be more vulnerable to severe pneumonia, due to…

In this article the authors aim to determine the risk of acute ischemic stroke in patients with severe and non-severe coronavirus disease 2019…

The literature on neurological manifestations in COVID-19 patients has been rapidly increasing with the pandemic. However, data on CNS inflammatory…

Little is known regarding long-term outcomes of patients hospitalized with COVID-19.

The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3…

Estimating rates of COVID-19 infection and associated mortality is challenging due to uncertainties in case ascertainment.